All entries in the Healthcare sector, newest first. tag:eurotrack.ai,2026:en:en/sectors/healthcare 2026-10-30T06:00:00Z Eurotrack tag:eurotrack.ai,2026:289f694f:en 2026-10-30T06:00:00Z

STRATEC has signed a contract to sell its subsidiary Diatron MI, with its haematology and clinical chemistry products, to an Indian investor consortium. The fixed price is €10.0m, plus performance-related components. The unit is expected to generate about €20m in revenue and an adjusted EBIT of roughly minus €10m in 2026; STRATEC books impairments of €44.1m in the third quarter and lowers its outlook. Closing is expected in the fourth quarter of 2026 (STRATEC SE, ad hoc release, 30 October 2026). — Source: https://www.finanznachrichten.de/nachrichten-2026-10/69994712-eqs-adhoc-stratec-se-stratec-verkauft-verlustbringenden-geschaeftsbereich-nimmt-wertminderungen-vor-und-passt-ausblick-an-022.htm

tag:eurotrack.ai,2026:28aa736c:en 2026-10-26T06:00:00Z

The dental clinic chain Vivanta has closed all its clinics since Monday because it ran out of money after the offer from Donte Group expired on 21 October. The insolvency proceedings are on hold until the European Commission rules on a €40m state rescue aid from 2022; the administrator and owners are preparing an orderly liquidation. The source gives no employee numbers (Cinco Días, 26 Oct 2026). — Source: https://cincodias.elpais.com/companias/2026-10-26/vivanta-cierra-todas-sus-clinicas-dentales-a-la-espera-del-pronunciamiento-de-bruselas.html

tag:eurotrack.ai,2026:a6e89a1c:en 2026-10-22T06:00:00Z

Investment firm Miura Partners has acquired a majority stake in Farmadosis through its Impact Fund. Farmadosis, based in Mallorca, supplies automated personalised medication dosing systems (over 50 employees, €15m revenue). The founder stays on as a minority shareholder, the price is not known, and Miura plans further add-on acquisitions (Expansión, 22 Oct 2026). — Source: https://www.expansion.com/catalunya/2026/10/22/miura-invierte-firma-dosificacion-medicamentos-farmadosis.html

tag:eurotrack.ai,2026:4bd2ef58:en 2026-10-21T06:00:00Z

On 21 October 2026 Qiagen signed a business combination agreement with EQT's bidder Crown NL Bidco: a voluntary public cash offer of €46.50 per share values the diagnostics group at about €10.8bn (enterprise value). According to the company, closing is planned for mid-2027 and depends on a minimum acceptance level and regulatory clearances, after which the stock market listings are to end. Qiagen also suspends its 2026 outlook (Qiagen, ad hoc notice, 21 Oct 2026; second source: RTTNews, 22 Oct 2026). — Sources: https://www.finanznachrichten.de/nachrichten-2026-10/69900484-eqs-adhoc-qiagen-n-v-abschluss-einer-vereinbarung-ueber-einen-unternehmenszusammenschluss-mit-eqt-private-equity-vorlaeufige-ergebnisse-fuer-das-3-q-022.htm · https://www.rttnews.com/3701422/qiagen-agrees-to-eqt-takeover-offer-for-all-outstanding-shares-at-46-50-share.aspx

tag:eurotrack.ai,2026:b35871be:en 2026-10-15T06:00:00Z

The Czech subsidiary of Germany's Hartmann group will give up its plant in Chvalkovice at the end of November 2027, affecting 280 employees plus 8 people at the Sanicare sheltered workshop, which also closes. About half of production is to move to the main plant in Veverská Bítýška (around 900 staff) and the rest to external partners in Asia; the company cites cost pressure from non-EU suppliers and fixed-price tenders. It already ended production at Havlíčkův Brod, with about 200 staff, in March 2026; some of the workforce may transfer to Veverská Bítýška (ČTK/České noviny, 15 Oct 2026). — Source: https://www.ceskenoviny.cz/zpravy/hartmann-rico-uzavre-v-listopadu-2027-zavod-chvalkovice/2888526

tag:eurotrack.ai,2026:98341d65:en 2026-09-28T06:00:00Z

The insolvent St Elisabeth Hospital in Salzgitter-Bad (108 beds, part of the Elisabeth Vinzenz Verbund) will cease operations on 30 September 2026; about 250 employees were told at an extraordinary staff meeting on 28 September. After the insolvency filing on 26 February 2026 and the opening of self-administered proceedings on 1 May 2026, there were interested parties but no binding takeover offer; the hospital cites uncertainty from the hospital reform, rising costs with inadequate reimbursement and heavy investment needs. Remaining patients were transferred, and a citizens' alliance and the mayor are protesting (kma Online, 28.09.2026; t-online, 29.09.2026). Update (7 Oct 2026): According to Ärzteblatt, all patients were to be transferred by the evening of 28 Sep 2026, the hospital had withdrawn from emergency care and ceased operations at the end of the month; the closure is thus complete (Ärzteblatt, 28 Sep 2026). — Sources: https://www.kma-online.de/aktuelles/klinik-news/detail/st-elisabeth-krankenhaus-salzgitter-stellt-den-betrieb-ein-56266 · https://www.aerzteblatt.de/news/krankenhaus-in-salzgitter-schliesst-457df582-069b-420a-91e1-8f23897b0c60

tag:eurotrack.ai,2026:c5e54f6a:en 2026-09-17T06:00:00Z

SBB is taking a 49% stake in Helsana's occupational health subsidiary HMS and will control it jointly with Helsana; the price is confidential and closing was planned for the end of October 2026. HMS carries out about 12,000 medical examinations a year for SBB alone; the European Commission cleared the deal the same day as case M.12356 (Keystone-SDA via nau.ch, 17 September 2026). — Sources: https://www.nau.ch/news/wirtschaft/sbb-steigen-mit-49-prozent-bei-helsana-tochter-hms-ein-67177764 · https://ec.europa.eu/commission/presscorner/detail/en/mex_26_1894

tag:eurotrack.ai,2026:1a0caeba:en 2026-09-16T06:00:00Z

Medical prosthetics maker Viant announced on 16 Sept 2026 the elimination of 114 of the 229 jobs at its Chaumont (Haute-Marne) site. The trigger is the loss of its largest customer, which accounted for around 85 % of revenue and is insourcing the affected production; the customer was not named. The social plan was due to start on 23 Sept 2026, and the specific positions affected had not yet been identified (France 3 Régions, 17 Sept 2026). — Source: https://france3-regions.franceinfo.fr/grand-est/haute-marne/chaumont/114-licenciements-annonces-dans-une-usine-c-est-lunaire-denonce-un-syndicaliste-3418475.html

tag:eurotrack.ai,2026:d1729a99:en 2026-08-05T06:00:00Z

On 5 August 2026 Vienna-based medical technology company P&F Products & Features GmbH announced the acquisition of AVVie GmbH, combining AVVie's research and development infrastructure and intellectual property with its own capabilities. At the heart of the deal is the AngelValve transcatheter platform for treating mitral valve regurgitation, which according to the company affects more than 13 million people in Europe and the United States. Financial terms were not disclosed (P&F press release distributed via PR Newswire). — Source: https://www.finanznachrichten.de/nachrichten-2026-08/69226272-p-f-products-features-gmbh-announces-acquisition-of-avvie-gmbh-008.htm

tag:eurotrack.ai,2026:d0b02310:en 2026-07-18T06:00:00Z

According to a statement on 18 July, Klinikum Leverkusen and the Catholic Alexianer group are exploring a possible transfer of the Alexianer St. Remigius hospital (Opladen site) to Klinikum Leverkusen; exploratory talks are under way. Alexianer regional managing director Benjamin M. Koch frames the move as regional responsibility for care provision (reported). — Source: https://lokalklick.eu/2026/07/18/klinikum-leverkusen-und-alexianer-pruefen-uebergang-des-alexianer-st-remigius-krankenhauses/

tag:eurotrack.ai,2026:c3f308b5:en 2026-07-07T06:00:00Z

EQT is buying Corza Medical's business built around the TachoSil haemostatic patch, with manufacturing in Linz and about 400 staff worldwide; no price or revenue was given and closing is expected in Q4 2026 (EQT, 7 July 2026). Update (23 September 2026): the European Commission cleared the deal as case M.12554 (European Commission, Daily News, 23 September 2026). — Sources: https://eqtgroup.com/news/eqt-to-acquire-the-tachosil-biosurgery-business-from-corza-medical-2026-07-07 · https://ec.europa.eu/commission/presscorner/detail/en/mex_26_1951

tag:eurotrack.ai,2026:de97d849:en 2026-06-29T06:00:00Z

Swedish care and social services provider Ambea made a recommended public offer for all shares in Humana on 29 Jun 2026 in order to combine the two companies; per share it offered SEK 20 in cash, 0.305 Ambea shares and a CVR instrument for a possible additional payment. Update (15 Oct 2026): after the extended acceptance period ended on 14 Oct 2026, holders of about 97.99% of Humana shares had accepted; Ambea will not extend further, is starting compulsory redemption of the remaining shares and Humana has applied to delist, with 27 Oct 2026 the last trading day. Settlement begins around 21 Oct 2026 (Ambea via Cision, 15 Oct 2026). Added later: the source does not state the total deal value. — Source: https://news.cision.com/se/ambea/r/ambea-ab--publ--offentliggor-slutligt-utfall-i-det-rekommenderade-offentliga-uppkopserbjudandet-till,c4409462

tag:eurotrack.ai,2026:c29b14bf:en 2026-05-06T06:00:00Z

The kidney care specialist Vantive, spun out of Baxter's kidney division in 2025 and acquired by Carlyle funds, is building a plant for plastic medical devices and consumables for kidney treatment on 16,000 m² in Ħal Far. 250 jobs are to be created; construction is due to start in 2026, completion is planned for 2027 and full operation for 2029. Prime Minister Abela called it the largest foreign direct investment in Malta's history (Lovin Malta, 6 May 2026; second source: Med-Tech World, 7 May 2026). — Sources: https://lovinmalta.com/news/local/new-e150-million-investment-in-medtech-to-create-250-high-quality-jobs/ · https://med-tech.world/news/vantive-commits-150-million-new-malta-facility/

tag:eurotrack.ai,2026:91a056d9:en 2026-03-16T06:00:00Z

Italian hearing care retailer Amplifon has signed a binding agreement with GN Store Nord to buy its entire hearing aid division GN Hearing (brands including ReSound and Beltone), valued at around €2.3bn on a cash- and debt-free basis. At completion GN will receive €1.69bn in cash and 56 million Amplifon shares, becoming the second-largest shareholder with about 16%; the combined group would have revenue of roughly €3.3bn in more than 100 countries. Closing is expected by the end of 2026, subject to the carve-out of GN Hearing from the GN group and regulatory approvals (Teleborsa, 16.03.2026; second source: The Hearing Review, 16.03.2026). Added on 03.10.2026. Update (29.09.2026): Amplifon has called an extraordinary and ordinary shareholders' meeting for 29.10.2026 to approve the capital increase of 56 million new shares reserved for GN Store Nord (worth about €631m), the share component of the purchase price; a GN representative is also to join the board once the deal closes (WebSim, 29.09.2026). — Sources: https://www.teleborsa.it/News/2026/03/16/ref-29.html · https://hearingreview.com/inside-hearing/industry-news/amplifon-to-acquire-gn-hearing-in-2-6-billion-deal · https://www.websim.it/azioni/blue-chip/amplifon-il-29-ottobre-l-assemblea-per-l-aumento-di-capitale/

tag:eurotrack.ai,2026:b7063c97:en 2026-01-22T06:00:00Z

Spital Oberengadin (the second-largest hospital in Graubünden after the Kantonsspital Chur) is in crisis. 50 employees are to be dismissed in order to avert a shutdown of operations. Reason: impending insolvency at the end of March 2026. A new ownership structure under the name Sanadura is planned (a public-law institution). The alternative: complete closure with the liquidation of all SGO operations and job losses for all 350 employees. At least 7 of the 11 participating municipalities must agree (votes in February/March 2026). Update (5 February 2026): Around 50 staff at Spital Oberengadin, mostly in nursing, were given notice and some found follow-on jobs; nine of the eleven owner municipalities backed the rescue plan. (SRF, 5 February 2026) — Sources: https://www.blick.ch/wirtschaft/das-letzte-wort-haben-die-stimmbuerger-buendner-krisenspital-will-50-angestellte-entlassen-id21622562.html · https://www.srf.ch/news/schweiz/gesundheitsversorgung-in-gr-spital-oberengadin-ist-gerettet

tag:eurotrack.ai,2026:b497e5c6:en 2026-01-22T06:00:00Z

Spital Oberengadin in Samedan GR (Graubünden's second-largest hospital after the Kantonsspital Chur) is in an existential crisis. SGO faces insolvency at the end of March 2026. A planned rescue takeover by the new public-law institution Sanadura would involve 50 dismissals. The alternative: complete closure and liquidation with job losses for all 350 employees and a collapse of healthcare provision in the region. At least 7 of the 11 participating Upper Engadine municipalities must approve by March (votes February/March 2026). Cross-reference: same case as the layoffs entry of the same day (rescue plan with 50 redundancies; full closure was the alternative scenario); the figure is carried there and set to null here to avoid double counting. Update (05.02.2026): The full closure has been averted: the member municipalities backed the rescue plan with the new public-law body Sanadura in early February 2026, and the hospital in Samedan is to continue operating from 1 April 2026 under Spital Oberengadin AG (KSGR group) (Medinside, 05.02.2026). — Source: https://www.blick.ch/wirtschaft/das-letzte-wort-haben-die-stimmbuerger-buendner-krisenspital-will-50-angestellte-entlassen-id21622562.html

tag:eurotrack.ai,2026:d5d9547c:en 2025-11-25T06:00:00Z

The insolvent hospital is being closed after takeover negotiations with IGPmed of Bonn failed. The last patients will be discharged on 28 November 2025, and 118 employees will receive notice of termination. The Linz-Remagen joint hospital had filed for insolvency at the end of March 2025; a solution was found for Linz. IGPmed wants to buy the property and attempt a reopening in the first half of 2026. — Source: https://www.swr.de/swraktuell/rheinland-pfalz/koblenz/verhandlungen-um-krankenhaus-remagen-gescheitert-klinik-schliesst-100.html

tag:eurotrack.ai,2026:9d17f602:en 2025-11-20T06:00:00Z

St. Joseph-Krankenhaus (450+ employees) has filed early for insolvency under self-administration due to chronic losses since 2021 and rising costs for personnel/energy. Hospital operations continue without restriction. Salaries are secured through insolvency benefit until January, and taken over again by the hospital from February. The Catholic sponsor can no longer provide financial support permanently. A structural realignment is planned, with closure ruled out by law (public services). Talks with politicians, cooperations, and a change of sponsor or investor are possible. Update (08.09.2026): The Eifelkreis Bitburg-Prüm district council voted unanimously to take over the insolvent hospital, which employs around 450 people; the district is to become sole shareholder from 01.10.2026. Operations continued throughout the insolvency proceedings; approval from the supervisory authority in Trier and the Diocese of Trier is still required (medinfoweb, 11.09.2026: https://medinfoweb.de/eifelkreis-bitburg-pruem-uebernimmt-insolventes-st-joseph-krankenhaus-pruem-ab-oktober/). — Source: https://www.swr.de/swraktuell/rheinland-pfalz/trier/krankenhaus-in-der-eifel-meldet-sich-insolvent-100.html

tag:eurotrack.ai,2026:083b9849:en 2025-11-19T06:00:00Z

The Federal Cartel Office has approved the acquisition of the hearing aid chain Kind by the Danish Demant Group. The combination creates Germany's largest hearing care chain with around 1,000 branches. Update (01.12.2025): Demant completed the acquisition of the Kind group after all conditions were met; the purchase price is €700m, and Kind, with around 650 clinics, is consolidated from 01.12.2025 (Demant stock exchange release, 01.12.2025). — Source: https://www.welt.de/regionales/niedersachsen/article691db5a276d3bd8e531d0009/hoergeraete-markt-kartellamt-erlaubt-neuen-branchen-riesen.html

tag:eurotrack.ai,2026:98ecb831:en 2025-11-18T06:00:00Z

Dispute over financing: the Mayen-Koblenz district council has voted for the drafting of a closure concept; the Boppard site faces shutdown. Update (11.03.2026): The Mayen-Koblenz district council revoked its closure decision for the Heilig-Geist hospital in Boppard (Gemeinschaftsklinikum Mittelrhein); the hospital is now regarded as secured for the medium term (Rhein-Zeitung, 11.03.2026: https://www.rhein-zeitung.de/lokales/andernach-mayen/belegschaft-von-heilig-geist-darf-aufatmen_arid-4110027.html). — Source: https://www.swr.de/swraktuell/rheinland-pfalz/koblenz/krankenhaus-boppard-vor-aus-gesellschafter-stimmen-fuer-schliessung-100.html

tag:eurotrack.ai,2026:247820cf:en 2025-11-13T06:00:00Z

The Ministry of Health of Mecklenburg-Western Pomerania approves the merger of Universitätsmedizin Greifswald with Klinikum Karlsburg. The university medical centre is acquiring the hospital for around €25 million; the combination is to be completed on 1 January 2026. Update (02.04.2026): According to Klinikum Karlsburg, Greifswald University Medicine acquired the hospital from the Hamburg-based Dr. Guth group at the start of 2026; the full merger of the two hospitals is planned for 01.01.2027 (klinikum-karlsburg.de, 02.04.2026: https://www.klinikum-karlsburg.de/allgemein/diabetes-versorgung-in-karlsburg-weiter-gestaerkt/). — Source: https://www.zeit.de/news/2025-11/13/mv-gesundheitsministerium-genehmigt-klinik-fusion

tag:eurotrack.ai,2026:70a74559:en 2025-10-23T06:00:00Z

Theresienkrankenhaus will be completely closed by the end of 2027 and relocated to the Diakonissen-Krankenhaus (Diako). Up to 350 employees will lose their jobs, with redundancies confirmed. Vascular surgery, ENT and urology are already closing at the end of 2025; pneumology follows in 2026. Reason: rising material/operating costs, digitalization costs, and a lack of funding compared with municipal hospitals. Originally planned for 2029, now accelerated. Around 29,000 inpatients and 59,000 outpatients annually across both sites. Update (1 July 2026): The hospital's closure has been completed — inpatients were moved to the Diako on 28 and 30 June 2026, the emergency department closed on 30 June 2026, and since 1 July 2026 the Brüderklinikum Julia Lanz has concentrated its wards and emergency care at the Diako site. Outpatient services such as a dialysis practice and an emergency-doctor base remain at the Theresienkrankenhaus (City of Mannheim, 15 June 2026). — Source: https://www.swr.de/swraktuell/baden-wuerttemberg/mannheim/theresienkrankenhaus-abteilungen-werden-geschlossen-100.html

tag:eurotrack.ai,2026:6f5405c0:en 2025-10-10T06:00:00Z

The private Helios clinic (Fresenius Group) is closing on 30 June 2026, with the emergency department already on 31 December 2025. Reason: below-average occupancy (avg. 51 of 123 beds), a lack of a successor chief physician for internal medicine, and new legal requirements from the hospital reform. 232 employees are affected; Helios offers transfers to other sites (Titisee-Neustadt, Müllheim). The city and district want to buy the building for a medical care center (MVZ) with surgery/orthopedics. The citizens' initiative 'Rettet unser Krankenhaus' is protesting against the closure. Update (08.04.2026): The full closure on 30.06.2026 has been averted – the town of Breisach is taking over the hospital from 01.07.2026, becoming its owner again for the first time since 1972 (gesundheitsmarkt.de, 16.04.2026, citing Badische Zeitung of 08.04.2026). — Source: https://www.swr.de/swraktuell/baden-wuerttemberg/suedbaden/schliessung-helios-rosmann-klinik-breisach-am-rhein-102.html

tag:eurotrack.ai,2026:9bd5f408:en 2025-07-15T06:00:00Z

The Archdiocese of Hamburg has discontinued operations; basic care provision in Wilhelmsburg has been discontinued (as of 15 July 2025). — Source: https://gesundheit-soziales-bildung.verdi.de/mein-arbeitsplatz/kirchliche-betriebe/++co++7ce40b40-ba38-11f0-8f9a-f18b7953e8e8

tag:eurotrack.ai,2026:2a086f47:en 2025-06-11T06:00:00Z

The Danish hearing aid manufacturer Demant is acquiring Germany's hearing care chain Kind, thereby becoming market leader in the German hearing aid market. Update (01.12.2025): Demant closed the Kind acquisition on 01.12.2025; with Kind's roughly 650 clinics and about 3,000 staff the group now runs more than 900 locations in Germany (Demant stock exchange announcement, 01.12.2025: https://view.news.eu.nasdaq.com/view?id=b901706e96839dcc83ef05fda16dd51d0&lang=en). — Source: https://www.reuters.com/en/demant-expands-german-through-700-million-euro-kind-deal-2025-06-11/